Evidence map›Paper›PMID 33498314›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Neurophysiological Effects of Whole Coffee Cherry Extract in Older Adults with Subjective Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study.

Jennifer L Robinson, Julio A Yanes, Meredith A Reid, Jerry E Murphy, Jessica N Busler, Petey W Mumford, Kaelin C Young, Zbigniew J Pietrzkowski, Boris V Nemzer, John M Hunter and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04986956 (Longitudinal Study to Assess the Effects of Whole Coffee Cherry Extract), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04986956 nacompletednot on this mapstarted 2022, after this paper: background citation

Longitudinal Study to Assess the Effects of Whole Coffee Cherry Extract (WCCE)

TypeinterventionalSponsorAuburn UniversityRan2022 to 2024Enrolled323ConditionsEffect of DrugArmsWhole coffee cherry extract, Placebo
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jennifer L RobinsonDepartment of Psychology, Auburn University, Auburn, AL 36849, USA.ORCID 0000-0001-7389-3047
Julio A YanesDepartment of Psychology, Auburn University, Auburn, AL 36849, USA.
Meredith A ReidAuburn University MRI Research Center, Auburn University, Auburn, AL 36849, USA.ORCID 0000-0003-1946-0544
Jerry E MurphyDepartment of Psychology, Auburn University, Auburn, AL 36849, USA.
Jessica N BuslerDepartment of Psychology, Auburn University, Auburn, AL 36849, USA.
Petey W MumfordSchool of Kinesiology, Auburn University, AL 36849, USA.
Kaelin C YoungSchool of Kinesiology, Auburn University, AL 36849, USA.
Zbigniew J PietrzkowskiVDF FutureCeuticals, Inc., 23 Peters Canyon Road, Irvine, CA 92606, USA.
Boris V NemzerVDF FutureCeuticals, Inc., 2692 N. State Route 1-17, Momence, IL 60954, USA.
John M HunterVDF FutureCeuticals, Inc., 2692 N. State Route 1-17, Momence, IL 60954, USA.
Darren T BeckInitiative for the Center for Neuroscience, Auburn University, AL 36849, USA.
Advanced Imaging Research (United States) · USAuburn University · USVan Drunen Farms (United States) · US

Funding

VDF FutureCeuticals, Inc. G00010324
6 · The paper itself

Abstract

Bioactive plant-based compounds have shown promise as protective agents across multiple domains including improvements in neurological and psychological measures. Methodological challenges have limited our understanding of the neurophysiological changes associated with polyphenol-rich supplements such as whole coffee cherry extract (WCCE). In the current study, we (1) compared 100 mg of WCCE to a placebo using an acute, randomized, double-blind, within-subject, cross-over design, and we (2) conducted a phytochemical analysis of WCCE. The primary objective of the study was to determine the neurophysiological and behavioral changes that resulted from the acute administration of WCCE. We hypothesized that WCCE would increase brain-derived neurotrophic factor (BDNF) and glutamate levels while also increasing neurofunctional measures in cognitive brain regions. Furthermore, we expected there to be increased behavioral performance associated with WCCE, as measured by reaction time and accuracy. Participants underwent four neuroimaging scans (pre- and post-WCCE and placebo) to assess neurofunctional/metabolic outcomes using functional magnetic resonance imaging and magnetic resonance spectroscopy. The results suggest that polyphenol-rich WCCE is associated with decreased reaction time and may protect against cognitive errors on tasks of working memory and response inhibition. Behavioral findings were concomitant with neurofunctional changes in structures involved in decision-making and attention. Specifically, we found increased functional connectivity between the anterior cingulate and regions involved in sensory and decision-making networks. Additionally, we observed increased BDNF and an increased glutamate/gamma-aminobutyric acid (GABA) ratio following WCCE administration. These results suggest that WCCE is associated with acute neurophysiological changes supportive of faster reaction times and increased, sustained attention.

Indexed as

7Tfunctional magnetic resonance imagingnutraceuticalspolyphenolsspectroscopy

Identifiers

PMID33498314
PMCPMC7909261
OpenAlexW3121434355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.